Real-world switching and switch-back patterns among patients transitioning from adalimumab to biosimilars in the United States (February 2023 to August 2025).

The Washington State Prescription Drug Affordability Board's selection of drugs for affordability review.

Association between comorbid depression, antidepressant adherence, and disease-modifying therapy adherence among Texas Medicaid patients with sickle cell disease.

Real-world treatment patterns, resource use, and costs in human epidermal growth factor receptor 2-negative advanced gastric/gastroesophageal junction cancer in the United States in the immune checkpoint inhibitor era.

The effectiveness and value of B-cell-directed therapies for the treatment of immunoglobulin A nephropathy.

Call for improved workforce planning for pharmacists in all industries to sustain the profession.

Real-world switching and switch-back patterns among patients transitioning from adalimumab to biosimilars in the United States (February 2023 to August 2025).

The Washington State Prescription Drug Affordability Board's selection of drugs for affordability review.

Association between comorbid depression, antidepressant adherence, and disease-modifying therapy adherence among Texas Medicaid patients with sickle cell disease.

Real-world treatment patterns, resource use, and costs in human epidermal growth factor receptor 2-negative advanced gastric/gastroesophageal junction cancer in the United States in the immune checkpoint inhibitor era.

The effectiveness and value of B-cell-directed therapies for the treatment of immunoglobulin A nephropathy.

Call for improved workforce planning for pharmacists in all industries to sustain the profession.